IOVANCE BIOTHERAPEUTICS, INC. financial data

Symbol
IOVA on Nasdaq
Location
San Carlos, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 24 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 350% % -20%
Quick Ratio 42% % 30%
Debt-to-equity 29% % 5%
Return On Equity -55% % -7.4%
Return On Assets -42% % -6.3%
Operating Margin -153% % 36%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 411,961,607 shares
Common Stock, Shares, Outstanding 411,938,061 shares 35%
Entity Public Float $534,800,000 USD -75%
Common Stock, Value, Issued $17,000 USD 31%
Weighted Average Number of Shares Outstanding, Basic 357,345 shares 23%
Weighted Average Number of Shares Outstanding, Diluted 334,511 shares 17%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $263,502,000 USD 61%
Cost of Revenue $173,184,000 USD 86%
Research and Development Expense $300,270,000 USD 8.7%
General and Administrative Expense $152,322,000 USD 0.04%
Costs and Expenses $666,858,000 USD 19%
Operating Income (Loss) $403,356,000 USD -2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $393,049,000 USD -4.8%
Income Tax Expense (Benefit) $2,071,000 USD 27%
Net Income (Loss) Attributable to Parent $390,978,000 USD -5.1%
Earnings Per Share, Basic -1.09 USD/shares 15%
Earnings Per Share, Diluted -1.21 USD/shares 28%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $163,078,000 USD 41%
Accounts Receivable, after Allowance for Credit Loss, Current $82,448,000 USD 19%
Inventory, Net $51,678,000 USD 0.31%
Assets, Current $442,689,000 USD -3.1%
Property, Plant and Equipment, Net $131,112,000 USD 20%
Operating Lease, Right-of-Use Asset $45,899,000 USD -17%
Other Assets, Noncurrent $8,166,000 USD 2113%
Assets $913,170,000 USD 0.3%
Accounts Payable, Current $22,159,000 USD -19%
Accrued Liabilities, Current $111,156,000 USD 36%
Liabilities, Current $138,358,000 USD 13%
Deferred Income Tax Liabilities, Net $31,828,000 USD -1.5%
Operating Lease, Liability, Noncurrent $44,401,000 USD 0.08%
Liabilities $214,587,000 USD 7.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax $16,440,000 USD
Retained Earnings (Accumulated Deficit) $2,775,530,000 USD -16%
Stockholders' Equity Attributable to Parent $698,583,000 USD -1.7%
Liabilities and Equity $913,170,000 USD 0.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $103,694,000 USD 15%
Net Cash Provided by (Used in) Financing Activities $143,315,000 USD -26%
Net Cash Provided by (Used in) Investing Activities $15,867,000 USD
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 411,938,061 shares 35%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $55,996,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $169,058,000 USD 39%
Deferred Tax Assets, Valuation Allowance $687,503,000 USD 23%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross $706,478,000 USD 23%
Operating Lease, Liability $48,444,000 USD -15%
Payments to Acquire Property, Plant, and Equipment $6,211,000 USD 49%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $373,492,000 USD 0.6%
Lessee, Operating Lease, Liability, to be Paid $80,835,000 USD -13%
Property, Plant and Equipment, Gross $179,882,000 USD 24%
Operating Lease, Liability, Current $4,043,000 USD -69%
Lessee, Operating Lease, Liability, to be Paid, Year Two $5,469,000 USD 0.31%
Lessee, Operating Lease, Liability, to be Paid, Year One $7,509,000 USD -56%
Operating Lease, Weighted Average Discount Rate, Percent 0.075 pure -5.1%
Deferred Income Tax Expense (Benefit) $1,838,000 USD -31%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $32,391,000 USD -9.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three $5,016,000 USD 16%
Deferred Tax Assets, Operating Loss Carryforwards $416,152,000 USD 37%
Unrecognized Tax Benefits $28,798,000 USD -3.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four $4,838,000 USD 10%
Operating Lease, Payments $15,125,000 USD -17%
Additional Paid in Capital $3,457,654,000 USD 12%
Amortization of Intangible Assets $23,077,000 USD -13%
Depreciation, Depletion and Amortization $11,466,000 USD -3.5%
Deferred Tax Assets, Net of Valuation Allowance $18,975,000 USD 12%